claim: hydroxychloroquine improves airflow and increases circulating ige levels in subjects with moderate symptomatic asthma
evidence_1: hydroxychloroquine (hcq) is a well-tolerated, safe immunomodulating drug, with proven efficacy in rheumatic diseases and known actions that suggest potential utility in the treatment of asthma.